DLBCL - Diffuse Large B Cell Lymphoma
47 clinical trials · Condition
◉ Watch DLBCL - Diffuse Large B Cell Lymphoma
| Record | Firm | Date |
|---|---|---|
| Health-Related Quality of Life Outcomes in Patients With Aggressive B-Cell Lymphomas Treated With CAR-T Cell Therapy in Real Life (NCT06026644) | Gruppo Italiano Malattie EMatologiche dell'Adulto | 2022-06-29 |
| CAR-T Followed by Bispecific Antibodies (NCT04889716) | Abramson Cancer Center at Penn Medicine | 2021-11-05 |
| An Italian Multicenter Retrospective Observational Study to Assess the Clinical Characteristics and the Outcome of Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma Treated With Polatuzumab Vedotin Plus Rituximab (± Bendamustine) Under Named Patient Programme (NCT06734078) | IRCCS Azienda Ospedaliero-Universitaria di Bologna | 2021-05-20 |
Track DLBCL - Diffuse Large B Cell Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.